388 related articles for article (PubMed ID: 33485186)
1. Generation of an induced pluripotent stem cell line, FJMUUHi001-A, from a hereditary Parkinson's disease patient with homozygous mutation of c.189dupA in PARK7.
Chen ZT; Zhao ZH; Chen LN; Fan F; Cai GE; Weng HD; Wang YQ; Liao LM; Chen XC; Huang E; Ye QY
Stem Cell Res; 2021 Mar; 51():102175. PubMed ID: 33485186
[TBL] [Abstract][Full Text] [Related]
2. Generation of a human iPSC line (CIBi013-A) from a patient with young-onset Parkinson's disease carrying a novel homozygous PARK7 (DJ-1) mutation.
Li L; Si X; Lei M; Yang J; Ruan J; Liu H; Huang F; Jin X; Xie K; Yang H; Lei X; Liu Y
Stem Cell Res; 2023 Feb; 66():102983. PubMed ID: 36469984
[TBL] [Abstract][Full Text] [Related]
3. Generation and characterization of a genetic Parkinson's disease-patient derived iPSC line DJ-1-delP (LCSBi008-A).
Mencke P; Boussaad I; Önal G; Kievit AJA; Boon AJW; Mandemakers W; Bonifati V; Krüger R
Stem Cell Res; 2022 Jul; 62():102792. PubMed ID: 35500378
[TBL] [Abstract][Full Text] [Related]
4. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
[TBL] [Abstract][Full Text] [Related]
5. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
6. Generation of iPSC line from a Parkinson patient with PARK7 mutation and CRISPR-edited Gibco human episomal iPSC line to mimic PARK7 mutation.
Mazza MC; Beilina A; Roosen DA; Hauser D; Cookson MR
Stem Cell Res; 2021 Aug; 55():102506. PubMed ID: 34419745
[TBL] [Abstract][Full Text] [Related]
7. Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene.
Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Mar; 27():90-94. PubMed ID: 29353703
[TBL] [Abstract][Full Text] [Related]
8. Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene.
Gustavsson N; Marote A; Pomeshchik Y; Russ K; Azevedo C; Chumarina M; Goldwurm S; Collin A; Pinto L; Salgado AJ; Klementieva O; Roybon L; Savchenko E
Stem Cell Res; 2019 Jan; 34():101373. PubMed ID: 30640063
[TBL] [Abstract][Full Text] [Related]
9. Characterization of human induced pluripotent stem cells line (PNUSCRi004-A) from a Parkinson's disease patient carrying L483P, A495P and V499V mutations.
Moon HJ; Lee N; Moon JY; Lee JH; Kim JH
Stem Cell Res; 2023 Apr; 68():103051. PubMed ID: 36805467
[TBL] [Abstract][Full Text] [Related]
10. Generation of an induced pluripotent stem cell line (GWCMCi005-A) from a patient with Lennox-Gastaut syndrome carrying TANC2 Gln1441Ter mutation.
Tian Y; Shi Z; Liao Y; Cai J; Li W; Li X; Chen WX
Stem Cell Res; 2022 Apr; 60():102667. PubMed ID: 35066241
[TBL] [Abstract][Full Text] [Related]
11. Generation of an induced pluripotent stem cell line (KNIHi001-A) by reprogramming peripheral blood mononuclear cells isolated from a patient with Parkinson's disease.
Baek D; Lee KG; Sohn HY; Park JH; Lee HK; Bayarsaikhan G; Yoo SW; Lee B; Kim JS; Koh YH; Kwon M
Stem Cell Res; 2024 Apr; 76():103358. PubMed ID: 38447455
[TBL] [Abstract][Full Text] [Related]
12. Establishment of PLAFMCi004-A induced pluripotent stem cells derived from PBMCs from a healthy individual.
Shang S; Chen K; Cai G; Bai X; Chen X; Li Q
Stem Cell Res; 2021 May; 53():102316. PubMed ID: 33878710
[TBL] [Abstract][Full Text] [Related]
13. Generation of an induced pluripotent stem cell line (GIBHi004-A) from a Parkinson's disease patient with mutant DJ-1/PARK7 (p.L10P).
Li Y; Ibañez DP; Fan W; Zhao P; Chen S; Md Abdul M; Jiang Y; Fu L; Luo Z; Liu Z; Yang Y; Guo J; Volpe G; Kanwal S; Wang D; Tang B; Li W
Stem Cell Res; 2020 Jul; 46():101845. PubMed ID: 32534165
[TBL] [Abstract][Full Text] [Related]
14. Reprogramming of a human induced pluripotent stem cell (iPSC) line (IBMSi012-A) from an early-onset Parkinson's disease patient harboring a homozygous p.D331Y mutation in the PLA2G6 gene.
Cheng YC; Lin HI; Syu SH; Lu HE; Huang CY; Lin CH; Hsieh PCH
Stem Cell Res; 2019 May; 37():101432. PubMed ID: 30978640
[TBL] [Abstract][Full Text] [Related]
15. Generation of an induced pluripotent stem cell line (CSC-41) from a Parkinson's disease patient carrying a p.G2019S mutation in the LRRK2 gene.
Marote A; Pomeshchik Y; Collin A; Goldwurm S; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Apr; 28():44-47. PubMed ID: 29414418
[TBL] [Abstract][Full Text] [Related]
16. Derivation of human induced pluripotent stem cell (iPSC) line from a 79year old sporadic male Parkinson's disease patient.
Zhang S; Liu L; Hu Y; Lv Z; Li Q; Gong W; Sha H; Wu H
Stem Cell Res; 2017 Mar; 19():43-45. PubMed ID: 28413004
[TBL] [Abstract][Full Text] [Related]
17. Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease.
Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Mar; 27():82-85. PubMed ID: 29334630
[TBL] [Abstract][Full Text] [Related]
18. Generation of an induced pluripotent stem cell line SDQLCHi026-A from a hereditary tyrosinemia type I patient carrying compound heterozygote mutations in FAH gene.
Zhang H; Liu C; Ma Y; Lin L; Lv Y; Gao M; Gai Z; Liu Y
Stem Cell Res; 2021 May; 53():102331. PubMed ID: 33882394
[TBL] [Abstract][Full Text] [Related]
19. Generation of induced pluripotent stem cells (IBMSi011-A) from a patient with Parkinson's disease carrying LRRK2 p.I1371V mutation.
Lin HI; Cheng YC; Ko HW; Wen CH; Lu HE; Huang CY; Hsieh PCH; Lin CH
Stem Cell Res; 2019 May; 37():101447. PubMed ID: 31029016
[TBL] [Abstract][Full Text] [Related]
20. Generation of an induced pluripotent stem cell line (CSC-32) from a patient with Parkinson's disease carrying a heterozygous variation p.A53T in the SNCA gene.
Azevedo C; Chumarina M; Serafimova E; Goldwurm S; Collin A; Roybon L; Savchenko E; Pomeshchik Y
Stem Cell Res; 2020 Mar; 43():101694. PubMed ID: 31954327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
